Finance

The acquisition bolsters CCC's AI-powered SaaS platform by adding transformative AI capabilities.

John Saran, a partner at Holland & Knight, says now that the election is over and uncertainty has been addressed, healthcare clients are generally optimistic and are anticipating a return to normal when it comes to deal making in 2025.

The company will use the funds to drive adoption of its platform and provide capital infusion for expansion in the health markets.

The company will use the funds to increase the development of its computational platform  to predict patient treatment responses and support drug research & development.   

The "game-changer" acquisition will integrate the Auckland-based company's healthcare data capabilities with AI.

Cindy Henry, director of population health informatics at ZeOmega, explores the recent trends in Star Ratings, the contributing factors behind lower scores across the board and strategies to adapt as the program's standards continue to rise.

Rami Karjian, head of the operating rooms business at LeanTaaS, says 17% of healthcare providers had to delay or cancel surgeries, which has a huge impact on patients, on the finances of a hospital and on caregivers who have to make up for the backlog.

AI and automation revenue cycle management tools will be accessible to 160,000 physicians.  

The company will fund and develop companies that focus on eight key areas in healthcare and create AI/genAI technologies that help advance those areas.

When considering a merger or acquisition, potential buyers should ask for the seller’s security policies and procedures, a risk analysis, and whether they have had recent security incidents, says Adam Greene, partner at Davis Wright Tremaine.